Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment
Glucocorticoids are widely used to suppress inflammation or the immune system. High
doses and long-term use of glucocorticoids lead to an important and common iatrogenic …
doses and long-term use of glucocorticoids lead to an important and common iatrogenic …
Osteoporosis and fractures in women: the burden of disease
Osteoporosis is a disease characterized by impaired bone microarchitecture and reduced
bone mineral density (BMD) resulting in bone fragility and increased risk of fracture. In …
bone mineral density (BMD) resulting in bone fragility and increased risk of fracture. In …
Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?
It is estimated that 2% to 3% of the population are currently prescribed systemic or topical
glucocorticoid treatment. The potent anti-inflammatory action of glucocorticoids to deliver …
glucocorticoid treatment. The potent anti-inflammatory action of glucocorticoids to deliver …
Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy
Osteoporosis associated with long-term glucocorticoid therapy remains a common and
serious bone disease. Additionally, in recent years it has become clear that more subtle …
serious bone disease. Additionally, in recent years it has become clear that more subtle …
Glucocorticoid-induced osteoporosis: 2019 concise clinical review
Glucocorticoids remain widely used for many medical conditions, and fractures are the most
serious common adverse event related to long-term glucocorticoid use. Glucocorticoid …
serious common adverse event related to long-term glucocorticoid use. Glucocorticoid …
Prevention and treatment of glucocorticoid-induced osteoporosis in adults: consensus recommendations from the Belgian bone club
MR Laurent, S Goemaere, C Verroken… - Frontiers in …, 2022 - frontiersin.org
Glucocorticoids are effective immunomodulatory drugs used for many inflammatory
disorders as well as in transplant recipients. However, both iatrogenic and endogenous …
disorders as well as in transplant recipients. However, both iatrogenic and endogenous …
Comparative effectiveness and cardiovascular safety of romosozumab versus teriparatide in patients with osteoporosis: a population-based cohort study
This study compared the effectiveness and cardiovascular safety of romosozumab and
teriparatide. The main finding was that there were no significant differences between the two …
teriparatide. The main finding was that there were no significant differences between the two …
Glucocorticoid-induced osteoporosis update
Glucocorticoid-induced osteoporosis update : Current Opinion in Rheumatology
Glucocorticoid-induced osteoporosis update : Current Opinion in Rheumatology Log in or …
Glucocorticoid-induced osteoporosis update : Current Opinion in Rheumatology Log in or …
Combination therapy of PTH and antiresorptive drugs on osteoporosis: a review of treatment alternatives
C Zhang, C Song - Frontiers in Pharmacology, 2021 - frontiersin.org
Antiresorptive drugs have been widely used for osteoporosis. Intermittent parathyroid
hormone (PTH), an anabolic agent, increases osteoblast production rate and inhibits …
hormone (PTH), an anabolic agent, increases osteoblast production rate and inhibits …
A bone targeting nanoparticle loaded ogp to restore bone homeostasis for osteoporosis therapy
S Ma, S Xu, M Li, Y Du, G Tian, J Deng… - Advanced …, 2023 - Wiley Online Library
Restoring bone homeostasis is the key to the treatment of osteoporosis. How to increase
osteogenic ability or inhibit osteoclast activity has always been a topic of great concern. In …
osteogenic ability or inhibit osteoclast activity has always been a topic of great concern. In …